Physician Assistant · San Antonio, TX
NPI
1467181362
Since 2022
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3326 Oakwell Ct
San Antonio, TX, 78218
Phone (210) 829-5180
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
1,065 services
Medicare patients, 2024
249
Average age 73
Drug cost, 2024
$1.1M
687 prescriptions
Company payments, 2025
$3,375
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher J Liendo was code 17003 (destruction skin lesion), 325 times for 58 patients. In total Christopher J Liendo billed 1,065 services in 14 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 325 | 58 | $3.79 | $1,230 |
| 99213 Office E&M - Established | Office | 289 | 170 | $47.86 | $14K |
| 17000 Destruction Skin Lesion | Office | 129 | 82 | $33.54 | $4,327 |
| 99203 Office E&M - New | Office | 86 | 86 | $58.10 | $4,997 |
| 17110 Destruction Skin Lesion | Office | 76 | 56 | $62.43 | $4,745 |
| 11102 Skin Biopsy | Office | 62 | 55 | $50.35 | $3,122 |
| 99214 Office E&M - Established | Office | 45 | 28 | $67.71 | $3,047 |
| 11103 Skin Biopsy | Office | 25 | 17 | $30.63 | $766 |
By year: 2022 $3,422 for 73 services; 2023 $34K for 889 services; 2024 $37K for 1,065 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher J Liendo prescribed most often to Medicare patients was Clobetasol Propionate, with 137 prescriptions and refills. In total Christopher J Liendo wrote 687 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 137 | 140 | 66 | $4,637 |
| Ketoconazole Generic | 116 | 122 | 54 | $1,935 |
| Hydrocortisone Generic | 70 | 71 | 42 | $408 |
| Odomzo Sonidegib Phosphate | 60 | 60 | Under 11 | $646K |
| Mupirocin Generic | 34 | 34 | 28 | $375 |
| Triamcinolone Acetonide Generic | 30 | 30 | 26 | $193 |
| Clindamycin Phosphate Generic | 26 | 27 | 14 | $871 |
| Doxycycline Hyclate Generic | 23 | 44 | 18 | $756 |
| Dupixent Pen Dupilumab | 19 | 19 | Under 11 | $71K |
| Prednisone Generic | 17 | 17 | 13 | $27.95 |
| Metronidazole Generic | 16 | 20 | Under 11 | $854 |
| Minocycline Hcl Generic | 15 | 31 | Under 11 | $323 |
| Cosentyx Unoready Pen Secukinumab | 12 | 12 | Under 11 | $173K |
Brand drugs: 117 claims; generic drugs: 570 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher J Liendo $3,375 ($3,375 in general payments such as food, travel and fees) from 18 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $480.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 13 | $480 |
| Abbvie Inc. ABBV | 23 | $373 |
| LEO Pharma Inc. | 15 | $330 |
| UCB, Inc. UCB.BR | 18 | $327 |
| Pfizer Inc. PFE | 25 | $298 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $288 |
| Genzyme Corporation SNY | 6 | $255 |
| Janssen Biotech, Inc. JNJ | 12 | $237 |
| Lilly USA, LLC LLY | 13 | $202 |
| Galderma Laboratories, L.P. GALD.SW | 11 | $162 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.